REGENXBIO Inc. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
5,387.00
4,003.00
22,811.00
62,967.00
73,169.00
99,937
Depreciation, Depletion & Amortization
-
-
80.00
544.00
2,686.00
3,982
Other Funds
289.00
494.00
3,256.00
8,636.00
11,594.00
8,503
Funds from Operations
5,676.00
3,509.00
19,475.00
53,787.00
58,889.00
112,422
Changes in Working Capital
2,664.00
1,110.00
3,006.00
5,229.00
897.00
7,774
Net Operating Cash Flow
3,012.00
2,399.00
22,481.00
48,558.00
57,992.00
104,648
Capital Expenditures
-
-
522.00
8,149.00
7,160.00
Purchase/Sale of Investments
-
-
163,278.00
27,312.00
2,370.00
Net Investing Cash Flow
-
-
163,800.00
19,163.00
4,790.00
Issuance/Reduction of Debt, Net
-
2,400.00
34.00
-
-
Net Financing Cash Flow
1,965.00
2,401.00
239,276.00
119.00
84,598.00
Net Change in Cash
1,047.00
2.00
52,995.00
29,276.00
21,816.00
Free Cash Flow
3,012.00
2,399.00
23,003.00
56,707.00
65,152.00
Change in Capital Stock
1,965.00
1.00
239,310.00
119.00
84,598.00
About REGENXBIO
View Profile
